Authors:
TRENQUE T
MARX C
QUEREUX C
LEROUX B
DUPOUY D
DORANGEON PH
CHOISY H
PINON JM
Citation: T. Trenque et al., HUMAN MATERNOFETAL DISTRIBUTION OF PYRIMETHAMINE-SULFADOXINE, British journal of clinical pharmacology, 45(2), 1998, pp. 179-180
Authors:
VILLENA I
CHEMLA C
QUEREUX C
DUPOUY D
LEROUX B
FOUDRINIER F
PINON JM
Citation: I. Villena et al., PRENATAL-DIAGNOSIS OF CONGENITAL TOXOPLASMOSIS TRANSMITTED BY AN IMMUNOCOMPETENT WOMAN INFECTED BEFORE CONCEPTION, Prenatal diagnosis, 18(10), 1998, pp. 1079-1081
Authors:
VILLENA I
AUBERT D
LEROUX B
DUPOUY D
TALMUD M
CHEMLA C
TRENQUE T
SCHMIT G
QUEREUX C
GUENOUNOU M
PLUOT M
BONHOMME A
PINON JM
Citation: I. Villena et al., PYRIMETHAMINE-SULFADOXINE TREATMENT OF CONGENITAL TOXOPLASMOSIS - FOLLOW-UP OF 78 CASES BETWEEN 1980 AND 1997, Scandinavian journal of infectious diseases, 30(3), 1998, pp. 295-300
Citation: Y. Cadroy et al., ARACHIDONIC-ACID ENHANCES THE TISSUE FACTOR EXPRESSION OF MONONUCLEAR-CELLS BY THE CYCLO-OXYGENASE-1 PATHWAY - BENEFICIAL EFFECT OF N-3 FATTY-ACIDS, The Journal of immunology, 160(12), 1998, pp. 6145-6150
Citation: Y. Cadroy et al., POLYMORPHONUCLEAR LEUKOCYTES (PMN) EXERT OPPOSITE REGULATORY EFFECTS ON TISSUE FACTOR (TF) PRODUCTION BY MONOCYTES (M) - ROLE OF REACTIVE OXYGEN SPECIES (ROS), Circulation, 98(17), 1998, pp. 586-586
Authors:
CADROY Y
DIQUELOU A
DUPOUY D
BOSSAVY J
SAKARIASSEN K
SIE P
BONEU B
Citation: Y. Cadroy et al., THE THROMBOMODULIN PROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY MODULATES THE THROMBOGENIC PROPERTIES OF THE NORMAL RESTING AND STIMULATED ENDOTHELIUM, Arteriosclerosis, thrombosis, and vascular biology, 17(3), 1997, pp. 520-527
Citation: Y. Cadroy et al., ARACHIDONIC-ACID (AA) ENHANCES THE TISSUE FACTOR (TF) EXPRESSION OF MONONUCLEAR-CELLS (MC) BY THE CYCLOXYGENASE-1 (COX-1) PATHWAY - BENEFICIAL EFFECT OF N-3 FATTY-ACIDS (FA), Thrombosis and haemostasis, 1997, pp. 810-810
Authors:
CADROY Y
GASPIN D
DUPOUY D
LORMEAU JC
BONEU B
SIE P
Citation: Y. Cadroy et al., HEPARIN REVERSES THE PROCOAGULANT PROPERTIES OF STIMULATED ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 75(1), 1996, pp. 190-195
Authors:
PINON JM
CHEMLA C
VILLENA I
FOUDRINIER F
AUBERT D
PUYGAUTHIERTOUBAS D
LEROUX B
DUPOUY D
QUEREUX C
TALMUD M
TRENQUE T
POTRON G
PLUOT M
REMY G
BONHOMME A
Citation: Jm. Pinon et al., EARLY NEONATAL DIAGNOSIS OF CONGENITAL TOXOPLASMOSIS - VALUE OF COMPARITIVE ENZYME-LINKED IMMUNOFILTRATION ASSAY IMMUNOLOGICAL PROFILES ANDANTITOXOPLASMA GONDII IMMUNOGLOBULIN-M (IGM) OR IGA IMMUNOCAPTURE ANDIMPLICATIONS FOR POSTNATAL THERAPEUTIC STRATEGIES, Journal of clinical microbiology, 34(3), 1996, pp. 579-583
Authors:
DIQUELOU A
DUPOUY D
CARIOU R
SAKARIASSEN KS
BONEU B
CADROY Y
Citation: A. Diquelou et al., A COMPARATIVE-STUDY OF THE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF UNFRACTIONATED HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN (FRAXIPARINE(R)) IN AN EXPERIMENTAL-MODEL OF HUMAN VENOUS THROMBOSIS, Thrombosis and haemostasis, 74(5), 1995, pp. 1286-1292
Authors:
DIQUELOU A
DUPOUY D
GASPIN D
CONSTANS J
SIE P
BONEU B
SAKARIASSEN KS
CADROY Y
Citation: A. Diquelou et al., RELATIONSHIP BETWEEN ENDOTHELIAL TISSUE FACTOR AND THROMBOGENESIS UNDER BLOOD-FLOW CONDITIONS, Thrombosis and haemostasis, 74(2), 1995, pp. 778-783
Authors:
DIQUELOU A
DUPOUY D
SIE P
SAKARIASSEN KS
BONEAU B
CADROY Y
Citation: A. Diquelou et al., SUPPRESSION OF THROMBOMODULIN EXPRESSION ENHANCES THE THROMBOGENICITYOF IL1-STIMULATED ENDOTHELIAL-CELLS AT VENOUS AND ARTERIAL-WALL SHEARRATES, Thrombosis and haemostasis, 73(6), 1995, pp. 899-899
Authors:
CADROY Y
GASPIN D
DUPOUY D
LORMEAU JC
BONEU B
SIE P
Citation: Y. Cadroy et al., ANTICOAGULANT AND NON-ANTICOAGULANT HEPARINS REVERSE THE PROCOAGULANTPROPERTIES OF STIMULATED ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 963-963
Authors:
IMBIMBO BP
SIE P
AGNELLI G
SAIVIN S
DUPOUY D
DAMIANI M
HOUIN G
GIANESE F
Citation: Bp. Imbimbo et al., INTRAMUSCULAR DERMATAN SULFATE MF701 IN PATIENTS WITH HIP FRACTURE - RELATIONSHIP BETWEEN PHARMACOKINETICS AND ANTITHROMBOTIC EFFICACY, Thrombosis and haemostasis, 71(5), 1994, pp. 553-557
Citation: P. Bendayan et al., DERMATAN SULFATE IS A MORE POTENT INHIBITOR OF CLOT-BOUND THROMBIN THAN UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARINS, Thrombosis and haemostasis, 71(5), 1994, pp. 576-580
Authors:
DIQUELOU A
LEMOZY S
DUPOUY D
BONEU B
SAKARIASSEN K
CADROY Y
Citation: A. Diquelou et al., EFFECT OF BLOOD-FLOW ON THROMBIN GENERATION IS DEPENDENT ON THE NATURE OF THE THROMBOGENIC SURFACE, Blood, 84(7), 1994, pp. 2206-2213
Authors:
CADROY Y
DIQUELOU A
LEMOZY S
DUPOUY D
SIE P
BONEU B
SAKARIASSEN KS
Citation: Y. Cadroy et al., THROMBIN FORMATION IS INFLUENCED BOTH BY THE NATURE OF THROMBOGENIC SURFACE AND THE SHEAR RATE, Thrombosis and haemostasis, 69(6), 1993, pp. 582-582
Authors:
CADROY Y
DIQUELOU A
DUPOUY D
SIE P
SAKARIASSEN KS
BONEU B
Citation: Y. Cadroy et al., LUMINAL SURFACE OF ENDOTHELIAL-CELLS STIMULATED BY INTERLEUKIN-1 AND ENDOTOXIN IS AS THROMBOGENIC AS THE RESPECTIVE EXTRACELLULAR-MATRIX ATVENOUS FLOW, Thrombosis and haemostasis, 69(6), 1993, pp. 1365-1365
Authors:
IMBIMBO BP
SIE P
AGNELLI G
DUPOUY D
DAMIANI M
GIANESE F
Citation: Bp. Imbimbo et al., PHARMACOKINETICS OF INTRAMUSCULAR DERMATAN SULFATE (MF701) IN PATIENTS WITH HIP FRACTURE, Thrombosis research, 70, 1993, pp. 74-74